1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Competitor Analysis: Cardiovascular Peptides

Competitor Analysis: Cardiovascular Peptides

  • October 2014
  • -
  • La Merie Publishing
  • -
  • 59 pages

Competitor Analysis: Cardiovascular Peptides


The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.


The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:



  • Drug Codes,

  • Target / Mechanism of Action,

  • Class of Compound,

  • Company,

  • Product category,

  • Indication,

  • R&D Stage and

  • additional comments with a hyperlink leading to the source of information.


About Competitor Analysis Series

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: Cardiovascular Peptides

Competitor Analysis: Cardiovascular Peptides


Table of Contents



  • 2013 Sales of Major Cardiovascular Peptides

  • Acute Care andamp; Reperfusion Injuries

  • Heart Failure

  • Coronary Ischemia andamp; Myocardial Infarction

  • Cardiometabolic Disease andamp; Atherosclerosis

  • Peripheral Vascular Disease

  • Hypertension

  • Pulmonary Artery Hypertension

  • Hemostasis, Wound Sealing andamp; Prevention of Thrombosis

  • Hematologic Diseases

  • Corporate Cardiovascular Peptide Randamp;D Pipelines

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast (2016-2022)

Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast (2016-2022)

  • $ 5422
  • Industry report
  • September 2016
  • by Industry ARC

Vascular graft procedures are minimally invasive besides involving repairing vessels from the inside as compared to other conventional vascular surgical procedure.In vascular graft procedures, Catheter-based ...

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

  • $ 4995
  • Industry report
  • October 2016
  • by GBI Research

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth Summary Cardiovascular disease (CVD) covers a range of difference ...

Global Left Atrial Appendage Closure Market 2017-2021

Global Left Atrial Appendage Closure Market 2017-2021

  • $ 3500
  • Industry report
  • January 2017
  • by Infiniti Research Limited

About Left Atrial Appendage Closure Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.